Table 5.
Independent variable | Odds Ratio (95% CI) | p |
---|---|---|
Core needle passes per patient | * | 0.04 |
Core needle gauge | ** | 0.99 |
Patient BMI | * | 0.69 |
Patient BMI ≥30 | 0.93 (0.21–4.80) | 0.99 |
Skin-to-tumor distance | * | 0.95 |
Skin-to-tumor distance ≥7 cm | 0.59 (0.14–2.48) | 0.52 |
Thickness of subcut. fat | * | 0.98 |
Thickness of subcut. fat ≥3 cm | 0.59 (0.14–3.07) | 0.47 |
Involvement of a trainee | 1.46 (0.33–6.00) | 0.53 |
Kidney laterality | 0.99 (0.24–4.37) | 0.99 |
Cortical location | *** | 0.83 |
Endophytic vs. exophytic | *** | 0.99 |
Mass size (cm) | * | 0.30 |
Mass size <4cm | 1.36 (0.25–14.08) | 0.99 |
Enhancement (<20HU) | ** | 0.99 |
Cystic | * | 0.83 |
*Numeric variable, therefore Wilcoxon two-sample rank-sum test was used for significance testing and the odds ratio was not calculated for individual pairs
**Insufficient data to run formal significance testing on this variable
***Odds Ratio was not calculated for individual pairs